PACB EBITDA | Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. (PACB) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$44.61M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$8.36M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$38.88M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$44.85M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2018-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$44.61M	(m)	$39.01M	(m)	$1.55M*	-$35.58M*	(m)	$23.02M	$33.39M	$58.00K
2026-03-31	Reported	(m)	-$8.36M	(m)	$37.18M	(m)	$3.04M	-$44.69M	(m)	$19.61M	$31.15M	$184.00K
2025-09-30	Reported	(m)	-$38.88M	(m)	$38.44M	(m)	-$86.00K*	-$18.71M*	(m)	$22.85M	$31.10M	$383.00K
2025-06-30	Reported	(m)	-$44.85M	(m)	$39.77M	(m)	$550.00K*	-$29.38M*	(m)	$22.53M	$36.17M	$35.00K
2025-03-31	Reported	(m)	-$428.93M	(m)	$37.15M	(m)	$1.39M	-$44.06M	(m)	$29.05M	$40.17M	-$302.00K
2024-09-30	Reported	(m)	-$64.08M	(m)	$39.97M	(m)	-$787.00K*	-$45.46M*	(m)	$25.52M	$43.75M	$0.00
2024-06-30	Reported	(m)	-$175.85M	(m)	$36.01M	(m)	$1.48M*	-$54.26M*	(m)	$38.48M	$45.88M	$0.00
2024-03-31	Reported	(m)	-$81.36M	(m)	$38.81M	(m)	$3.88M	-$75.68M	(m)	$43.45M	$43.75M	$0.00
2023-09-30	Reported	(m)	-$82.49M	(m)	$55.69M	(m)	$830.00K*	-$65.18M*	(m)	$47.51M	$43.43M	-$10.71M
2023-06-30	Reported	(m)	-$73.17M	(m)	$47.57M	(m)	$2.27M*	-$41.74M*	(m)	$46.17M	$40.57M	$0.00
2023-03-31	Reported	(m)	-$91.25M	(m)	$38.90M	(m)	$3.72M	-$94.69M	(m)	$48.94M	$39.82M	$0.00
2022-09-30	Reported	(m)	-$74.62M	(m)	$32.31M	(m)	$4.19M*	-$63.05M*	(m)	$47.09M	$36.80M	$0.00
2022-06-30	Reported	(m)	-$67.97M	(m)	$35.47M	(m)	$4.02M*	-$60.56M*	$15.50M	$50.35M	$39.25M	$0.00
2022-03-31	Reported	(m)	-$77.52M	(m)	$33.17M	(m)	$3.64M	-$79.03M	$14.82M	$52.94M	$39.80M	$0.00
2021-09-30	Reported	(m)	-$74.48M	(m)	$34.89M	(m)	$1.12M*	-$40.66M*	$19.52M	$27.51M	$31.61M	-$94.82M
2021-06-30	Reported	(m)	-$37.57M	(m)	$30.61M	(m)	$1.57M*	-$15.71M*	$13.22M	$22.27M	$29.06M	(m)
2021-03-31	Reported	(m)	-$33.71M	(m)	$29.00M	(m)	$401.00K	-$23.10M	$12.70M	$20.55M	$26.14M	(m)
2020-09-30	Reported	(m)	-$24.18M	(m)	$19.08M	(m)	$536.00K*	-$17.81M*	$12.02M	$16.47M	$14.77M	(m)
2020-06-30	Reported	(m)	-$23.52M	(m)	$19.08M	(m)	$319.00K*	-$23.79M*	$10.46M	$15.01M	$15.13M	(m)
2020-03-31	Reported	(m)	-$32.71M	(m)	$15.60M	(m)	$117.00K	$75.36M	$8.11M	$15.25M	$24.95M	(m)
2019-12-31	Reported	(m)	-$17.92M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$28.11M	(m)	$21.91M	(m)	$829.00K*	-$17.26M*	$15.00M	$14.96M	$20.07M	(m)
2019-06-30	Reported	(m)	-$24.38M	(m)	$24.62M	(m)	$613.00K*	-$17.56M*	$15.01M	$14.91M	$19.08M	(m)
2019-03-31	Reported	(m)	-$30.13M	(m)	$16.43M	(m)	$1.25M	-$25.31M	$11.31M	$15.48M	$19.77M	(m)
2018-12-31	Reported	(m)	-$30.62M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	-$24.67M	(m)	$18.16M	(m)	$96.00K*	-$14.18M*	$14.97M	$14.36M	$13.51M	(m)
2018-06-30	Reported	(m)	-$21.75M	(m)	$21.58M	(m)	$1.36M*	-$14.50M*	$12.72M	$15.66M	$14.94M	(m)
2018-03-31	Reported	(m)	-$23.95M	(m)	$19.36M	(m)	$344.00K	-$18.77M	$12.07M	$16.31M	$14.93M	(m)
2017-12-31	Reported	(m)	-$20.53M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$21.57M	(m)	$23.55M	(m)	$3.26M*	-$17.84M*	$15.32M	$15.84M	$13.95M	(m)
2017-06-30	Reported	(m)	-$24.39M	(m)	$20.07M	(m)	$3.45M*	-$12.81M*	$12.07M	$16.88M	$15.51M	(m)
2017-03-31	Reported	(m)	-$23.30M	(m)	$24.91M	(m)	$2.67M	-$16.67M	(m)	$16.97M	$15.27M	(m)
2016-12-31	Reported	(m)	-$17.87M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$16.73M	(m)	(m)	(m)	$2.30M*	(m)	(m)	$17.48M	$11.89M	(m)
2016-06-30	Reported	(m)	-$18.07M	(m)	(m)	(m)	$2.80M*	(m)	(m)	$17.52M	$11.19M	(m)
2016-03-31	Reported	(m)	-$18.57M	(m)	(m)	(m)	$457.00K	(m)	(m)	$16.36M	$11.71M	(m)
2015-12-31	Reported	(m)	-$1.06M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	$2.61M	(m)	(m)	(m)	$459.00K*	(m)	(m)	$16.16M	$10.82M	(m)
2015-06-30	Reported	(m)	-$11.36M	(m)	(m)	(m)	$955.00K*	(m)	(m)	$15.04M	$10.82M	(m)
2015-03-31	Reported	(m)	-$19.33M	(m)	(m)	(m)	$717.00K	(m)	(m)	$14.48M	$10.77M	(m)
2014-12-31	Reported	(m)	-$17.89M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$8.41M	(m)	(m)	(m)	$190.00K*	(m)	(m)	$11.69M	$9.88M	(m)
2014-06-30	Reported	(m)	-$18.30M	(m)	(m)	(m)	$465.00K*	(m)	(m)	$12.44M	$8.99M	(m)
2014-03-31	Reported	(m)	-$18.25M	(m)	(m)	(m)	$477.00K	-$16.26M	(m)	$11.77M	$9.15M	(m)
2013-12-31	Reported	(m)	-$17.00M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$19.93M	(m)	(m)	(m)	$230.00K*	$18.72M*	(m)	$10.42M	$10.76M	(m)
2013-06-30	Reported	(m)	-$20.00M	(m)	(m)	(m)	$280.00K*	-$16.41M*	(m)	$11.68M	$9.37M	(m)
2013-03-31	Reported	(m)	-$20.61M	(m)	(m)	(m)	$297.00K	-$17.57M	(m)	$11.98M	$9.55M	(m)
2012-12-31	Reported	(m)	-$21.69M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	(m)	-$22.58M	(m)	(m)	(m)	$482.00K*	-$17.65M*	(m)	$12.63M	$10.14M	(m)
2012-06-30	Reported	(m)	-$22.55M	(m)	(m)	(m)	$507.00K*	-$23.61M*	(m)	$11.27M	$11.56M	(m)
2012-03-31	Reported	(m)	-$27.51M	(m)	(m)	(m)	$274.00K	-$17.34M	(m)	$12.07M	$15.29M	(m)
2011-03-31	Reported	(m)	-$34.97M	(m)	(m)	(m)	$1.50M	-$33.46M	(m)	$24.12M	$11.12M	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$553.86M	(m)	(m)	(m)	$2.71M	-$111.21M	(m)	$97.31M	$141.49M	$318.00K
2024-12-31	Reported	(m)	-$474.31M	(m)	(m)	(m)	$6.19M	-$206.06M	(m)	$134.92M	$175.02M	$316.00K
2023-12-31	Reported	(m)	-$334.47M	(m)	(m)	(m)	$8.84M	-$259.17M	(m)	$187.17M	$169.82M	-$11.42M
2022-12-31	Reported	(m)	-$307.20M	(m)	(m)	(m)	$16.75M	-$263.21M	(m)	$193.00M	$160.85M	$0.00
2021-12-31	Reported	(m)	-$210.44M	(m)	(m)	(m)	$5.93M	-$111.18M	(m)	$112.90M	$124.12M	-$93.65M
2020-12-31	Reported	(m)	-$104.39M	(m)	(m)	(m)	$1.04M	$19.50M	$46.33M	$64.15M	$72.80M	(m)
2020-09-30	Rolling	(m)	-$98.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$102.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$103.12M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$100.55M	(m)	(m)	(m)	$2.84M	-$78.31M	$56.31M	$59.63M	$75.49M	(m)
2019-12-31	Rolling	(m)	-$100.55M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$113.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$109.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$107.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$93.77M	(m)	(m)	(m)	-119.26%	$1.85M	-$66.43M	$53.53M	$62.59M	$63.49M	(m)
2018-12-31	Rolling	(m)	-$100.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$90.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$87.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$90.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$81.34M	(m)	(m)	(m)	-87.03%	$10.43M	-$67.52M	$58.81M	$65.32M	$59.12M	(m)
2017-12-31	Rolling	(m)	-$89.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$87.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$82.30M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$75.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$67.37M	(m)	(m)	(m)	-74.27%	$8.21M	-$67.93M	$46.55M	$67.62M	$47.79M	(m)
2016-12-31	Rolling	(m)	-$71.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$54.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$35.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$28.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$25.46M	(m)	(m)	(m)	-27.44%	$3.01M	(m)	(m)	$60.44M	$45.19M	(m)
2015-12-31	Rolling	(m)	-$29.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$45.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$56.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$63.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$58.63M	(m)	(m)	(m)	-96.76%	$1.61M	(m)	(m)	$48.23M	$38.03M	(m)
2014-12-31	Rolling	(m)	-$62.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$61.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$73.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$75.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$71.9M	(m)	(m)	(m)	-255.12%	$909.00K	-$29.83M	(m)	$45.22M	$38.74M	(m)
2013-12-31	Rolling	(m)	-$77.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$82.23M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$84.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$87.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$87.69M	(m)	(m)	(m)	-337.49%	$1.70M	-$76.82M	(m)	$47.62M	$47.66M	(m)
2012-12-31	Rolling	(m)	-$94.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$103.95M	(m)	(m)	(m)	-306.98%	$9.28M	-$102.97M	(m)	$76.08M	$46.71M	(m)
2010-12-31	Reported	(m)	(m)	$5.16M	(m)	(m)	$5.26M	-$122.00M	(m)	$111.82M	$30.09M	(m)
2009-12-31	Reported	(m)	(m)	$4.10M	(m)	(m)	$5.18M	-$74.84M	(m)	$75.88M	$12.33M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
908 Devices Inc. (MASS)	United States	$0.476B	-9.53
EyePoint, Inc. (EYPT)	United States	$0.314B	-3.96
Cytek Biosciences, Inc. (CTKB)	United States	$0.744B	-7.15
Quanterix Corp (QTRX)	United States	$0.150B	-1.65
Nautilus Biotechnology, Inc. (NAUT)	United States	$0.129B	-4.16
Seer, Inc. (SEER)	United States	$0.104B	-1.34
Precipio, Inc. (PRPO)	United States	$0.043B	-36.70
HARVARD BIOSCIENCE INC (HBIO)	United States	$0.037B	-2.70
Bionano Genomics, Inc. (BNGO)	United States	$0.020B	-0.42
ASTROTECH Corp (ASTC)	United States	$0.013B